2021-01-05,Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
2020-12-11,Is VRNA A Good Stock To Buy Now?
2020-11-24,25 Best U.S. Cities to Live With Asthma
2020-11-23,Verona Pharma Secures up to $30 Million Debt Financing from Silicon Valley Bank
2020-11-09,Verona Pharma Announces November 2020 Virtual Investor Conference Participation
2020-10-29,Verona Pharma Plcto Host Earnings Call
2020-10-29,"Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020"
2020-10-28,Verona Pharma plc : Update on AIM Delisting
2020-10-22,"Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update"
2020-10-13,Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020
2020-09-24,Verona (VRNA) Initiates Pivotal COPD Studies on Ensifentrine
2020-09-23,Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
2020-09-21,Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM
2020-09-17,Verona Pharma to Ring the Nasdaq Closing Bell to celebrate $200 million financing
2020-09-16,Verona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary Disease
2020-09-08,Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
2020-09-02,Verona Pharma to Present at H.C. Wainwright 22nd Annual Global Virtual Investment Conference
2020-08-26,Verona Pharma plc: Grant of RADSUs and PDMR Dealings
2020-08-24,Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2020
2020-08-19,Verona Up 10% On Lung Trial Kick Off; Analyst Initiates Stock At Buy
2020-08-19,Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD
2020-08-14,Why Verona Pharma Stock Is Vaulting Higher Today
2020-08-14,"Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020"
2020-08-12,Has Verona Pharma PLC American Depositary Share (VRNA) Outpaced Other Medical Stocks This Year?
2020-08-10,"Benzinga's Top Upgrades, Downgrades For August 10, 2020"
2020-08-07,Verona Pharma plc: TR-1: Standard form for notification of major holdings
2020-08-06,Top Ranked Momentum Stocks to Buy for August 6th
2020-08-04,"Verona Pharma plc: Issue of Equity, PDMR Dealings & Total Voting Rights"
2020-08-04,Top Ranked Momentum Stocks to Buy for August 4th
2020-08-03,Verona Pharma Announces August 2020 Virtual Investor Conference Participation
2020-07-31,Top Ranked Momentum Stocks to Buy for July 31st
2020-07-30,Verona Pharma plc: TR-1: Standard form for notification of major holdings
2020-07-30,"Verona Pharma to Announce Interim Results for the Three and Six Months Ended June 30, 2020 and Provide Corporate Update"
2020-07-29,Top Ranked Momentum Stocks to Buy for July 29th
2020-07-28,Top Ranked Momentum Stocks to Buy for July 28th
2020-07-27,Verona Pharma plc: TR-1: Standard form for notification of major holdings
2020-07-23,Will Verona Pharma Continue to Surge Higher?
2020-07-22,"Closing of Financing, Issued Share Capital and Total Voting Rights"
2020-07-17,Verona Pharma plc: PDMR Dealings
2020-07-17,Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
2020-07-06,Verona Pharma plc: Issue of Equity and Total Voting Rights
2020-05-14,Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program
2020-05-12,"Director/PDMR Shareholding - Grant of Restricted Stock Units, Issue of Equity, Total Voting Rights & PDMR Dealings"
2020-05-01,Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference
2020-04-30,"Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020"
2020-04-23,"Verona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate Update"
2020-04-17,Will Verona Pharma Continue to Surge Higher?
2020-04-16,Verona Pharma plc: Results of AGM
2020-04-14,Here's Why Verona Pharma (LON:VRP) Must Use Its Cash Wisely
2020-04-08,Update on AGM Procedure
2020-03-31,Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD
2020-03-20,Verona Pharma plc: Issue of Equity and Total Voting Rights
2020-03-18,Abeona Treats First Patient in Pivotal Gene Therapy Study
2020-03-16,2019 Annual Report and Accounts and Notice of AGM
2020-03-05,Grant of Restricted Stock Units and PDMR Dealings
2020-02-27,"Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corporate Update"
2020-02-21,"Verona Pharma plc to Announce Financial Results for Full Year Ended December 31, 2019 and Provide Corporate Update"
2020-02-14,Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research
2020-02-07,Holding(s) in Company TR-1: Standard form for notification of major holdings
2020-02-03,Verona Pharma Announces Senior Management Changes
2020-01-28,Verona Pharma to Present at LSX World Congress 2020
2020-01-17,Holding(s) in Company TR-1: Standard form for notification of major holdings
2020-01-13,Verona Pharma shares shoot higher on Phase 2 trial of respiratory drug
2020-01-10,Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
2020-01-07,"Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations"
2020-01-03,Riding December's Momentum Into 2020
2019-11-28,Holding(s) in Company TR-1: Standard form for notification of major holdings
2019-11-27,Verona Pharma plc: Grant of Options to PDMR
2019-11-18,Verona Pharma plc: PDMR Dealing  Purchase by Chairman
2019-11-14,Verona Pharma plc: PDMR Dealing  Purchase by Chairman
2019-11-13,Verona Pharma to Present at Jefferies 2019 London Healthcare Conference
2019-11-11,Verona Pharma to Participate in Two Upcoming Institutional Investor Conferences in New York
2019-11-05,"Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2019"
2019-10-29,"Verona Pharma to Announce Financial Results for the Three and Nine Months Ended September 30, 2019 and Provide Clinical Development Update"
2019-10-17,Here's Why We're Watching Verona Pharma's (LON:VRP) Cash Burn Situation
2019-10-17,Verona Pharma Completes Enrollment in Phase 2b Clinical Trial with Nebulized Ensifentrine in moderate-to-severe COPD
2019-10-15,Verona Pharma to Present Phase 2 Symptom Data with Ensifentrine in COPD at CHEST 2019
2019-09-19,Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory Society International Congress 2019
2019-09-09,Holding(s) in Company TR-1: Standard form for notification of major holdings
2019-09-03,Verona Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference
2019-08-09,Verona Pharma plc: PDMR Dealing
2019-08-06,"Verona Pharma plc: Operational Update and Financial Results for the Three and Six Months Ended June 30, 2019"
2019-08-05,Verona Pharma Reports Positive Phase 2 Results with Dry Powder Inhaler Formulation of Ensifentrine in COPD
2019-07-30,"Verona Pharma to Announce Financial Results for Second Quarter Ended June 30, 2019 and Provide Clinical Development Update"
2019-07-24,Verona Pharma to Attend BTIG Biotechnology Conference 2019 and Present at 2019 Wedbush PacGrow Healthcare Conference
2019-06-25,Verona Pharma Strengthens its Clinical Team Ahead of Phase 3 Development of Ensifentrine
2019-06-04,Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD
2019-05-30,Verona Pharma to Present at Jefferies 2019 Global Healthcare Conference
2019-05-20,Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at American Thoracic Society 2019 International Conference
2019-05-07,Result of AGM
2019-05-07,"Verona Pharma plc Operational Update and Financial Results for the Three Months Ended March 31, 2019"
2019-05-07,Verona Pharma Initiates Additional Phase 2b Clinical Trial with Nebulized Ensifentrine to Inform Dose Selection for Phase 3 Trials
2019-05-02,Verona Pharma to Present Clinical Trial Data of Ensifentrine for COPD Maintenance Treatment at American Thoracic Society 2019 International Conference
2019-05-01,"Verona Pharma to Announce Financial Results for First Quarter Ended March 31, 2019 and Provide Clinical Development Update"
2019-05-01,"Verona Pharma plc (""Verona"" or the ""Company"") Appointment of Nominated Adviser and UK Broker"
2019-04-25,"Verona Pharma to Host Investor & Analyst R&D Forum in London on May 8, 2019"
2019-04-09,Verona Pharma Granted Key EU Patent Related to Late-stage COPD Clinical Candidate Ensifentrine
2019-04-04,Grant of Options and RSUs and PDMR Dealings
2019-03-26,Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference
2019-03-25,PDMR Dealing
